UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines

Annals of oncology, 2010-02, Vol.21 (2), p.255-262

2010

Volltextzugriff (PDF)

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

Annals of oncology, 2007-02, Vol.18 (2), p.317-323

2007

Volltextzugriff (PDF)

Emerging ethnic differences in lung cancer therapy

British journal of cancer, 2008-12, Vol.99 (11), p.1757-1762

2008

Volltextzugriff (PDF)

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

Annals of oncology, 2013-01, Vol.24 (1), p.20-30

2013

Volltextzugriff (PDF)

A phase II trial of dose-dense chemotherapy, followed by surgical resection and or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)

British journal of cancer, 2010-06, Vol.103 (1), p.6-11

2010

Volltextzugriff (PDF)

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer : JCOG 9702

British journal of cancer, 2007-07, Vol.97 (2), p.162-169

2007

Volltextzugriff (PDF)

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo

Oncogene, 2011-10, Vol.30 (43), p.4386-4398

2011

Volltextzugriff (PDF)

Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402)

Annals of oncology, 2012-09, Vol.23 (9), p.2253-2258

2012

Volltextzugriff (PDF)

Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104)

Annals of oncology, 2009-05, Vol.20 (5), p.835-841

2009

Volltextzugriff (PDF)

A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)

British journal of cancer, 2009-02, Vol.100 (3), p.464-469

2009

Volltextzugriff (PDF)

PL 04.02 Where We Are Now, and Where We Will Be in 10 years: From Asian Perspective

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1608-S1608

Saijo, N.

2017

Volltextzugriff (PDF)

Homozygous CDA3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients

British journal of cancer, 2009-03, Vol.100 (6), p.870-873

2009

Volltextzugriff (PDF)

Progress in treatment of small-cell lung cancer: role of CPT-11

British journal of cancer, 2003-12, Vol.89 (12), p.2178-2183

Saijo, N

2003

Volltextzugriff (PDF)

Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation

British journal of cancer, 2011-10, Vol.105 (9), p.1267-1272

2011

Volltextzugriff (PDF)

Anticancer Drug Discovery and Development Throughout the World

Journal of clinical oncology, 2002-09, Vol.20 (suppl 1), p.47s-59s

2002

Volltextzugriff (PDF)

What are the reasons for negative phase III trials of molecular‐target‐based drugs?

Cancer science, 2004-10, Vol.95 (10), p.772-776

Saijo, Nagahiro

2004

Volltextzugriff (PDF)

A phase-II trial of dose-dense chemotherapy in patients with disseminated thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9605)

British journal of cancer, 2009-11, Vol.101 (9), p.1549-1554

2009

Volltextzugriff (PDF)

Haplotype structures of the UGT1A gene complex in a Japanese population

The pharmacogenomics journal, 2006-01, Vol.6 (1), p.63-75

2006

Volltextzugriff (PDF)

Phase I–II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer

Annals of oncology, 2005-03, Vol.16 (3), p.430-436

2005

Volltextzugriff (PDF)

A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients

Annals of oncology, 2004-01, Vol.15 (1), p.45-50

2004

Volltextzugriff (PDF)

Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel

Annals of oncology, 2009-09, Vol.20 (9), p.1483-1488

2009

Volltextzugriff (PDF)

Reply to 'Malignant pericardial effusion: sclerotherapy or local chemotherapy?'

British journal of cancer, 2009-08, Vol.101 (4), p.736-737

2009

Volltextzugriff (PDF)

Preclinical and Clinical Trials of Topoisomerase Inhibitors

Annals of the New York Academy of Sciences, 2000-01, Vol.922 (1), p.92-99

SAIJO, NAGAHIRO

2000

Volltextzugriff (PDF)

3066 POSTER Erythropoiesis-stimulating Agents for the Treatment of Chemotherapy-induced Anemia and Mortality: a Meta-analysis of Individual Patient Data From Japanese Randomized Trials

European journal of cancer (1990), 2011, Vol.47, p.S242-S242

2011

Volltextzugriff (PDF)

Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial

The lancet oncology, 2010-07, Vol.11 (7), p.619-626

2010

Volltextzugriff (PDF)

1 – 25 von 1.091

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(926)
Mit Volltextzugriff
(892)

Publikationsform

Sprache

Englisch
(969)
Japanisch
(135)
Deutsch
(2)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(633)
Science & Technology
(597)
Life Sciences & Biomedicine
(559)
Oncology
(383)
Biological And Medical Sciences
(355)
Medical Sciences
(332)
Male
(312)
Female
(305)
Lung Neoplasms - Drug Therapy
(235)
Middle Aged
(230)
Pharmacology. Drug Treatments
(222)
Aged
(212)
Antineoplastic Agents
(195)
Adult
(178)
Animals
(158)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(126)
Chemotherapy
(124)
Lung Neoplasms - Pathology
(124)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(110)
Tumor Cells, Cultured
(109)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(736)
EZB Electronic Journals Library
(642)
Journals@OVID
(460)
Ingenta
(418)
Publisher website
(285)
IngentaConnect Journals
(198)
Elsevier ScienceDirect Journals
(171)
Wiley Online Library Journals
(162)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(140)
Oxford University Press Journals Current
(107)
Oxford Journals 2020 Medicine
(100)
Wiley Online Library Full Collection 2018
(80)
SpringerLink_现刊
(76)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(73)
Nature
(52)
IEEE Electronic Library Online
(24)
SpringerLink Series
(13)
Nexis Uni
(12)
JSTOR Complete Journals
(8)
Sage Journals
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

Emerging ethnic differences in lung cancer therapy

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

A phase II trial of dose-dense chemotherapy, followed by surgical resection and or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer : JCOG 9702

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo

Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402)

Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104)

A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)

PL 04.02 Where We Are Now, and Where We Will Be in 10 years: From Asian Perspective

Homozygous CDA3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients

Progress in treatment of small-cell lung cancer: role of CPT-11

Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation

Anticancer Drug Discovery and Development Throughout the World

What are the reasons for negative phase III trials of molecular‐target‐based drugs?

A phase-II trial of dose-dense chemotherapy in patients with disseminated thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9605)

Haplotype structures of the UGT1A gene complex in a Japanese population

Phase I–II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer

A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients

Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel

Reply to 'Malignant pericardial effusion: sclerotherapy or local chemotherapy?'

Preclinical and Clinical Trials of Topoisomerase Inhibitors

3066 POSTER Erythropoiesis-stimulating Agents for the Treatment of Chemotherapy-induced Anemia and Mortality: a Meta-analysis of Individual Patient Data From Japanese Randomized Trials

Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial

Suchergebnisse filtern